About Flax Health
Flax Technologies, Inc. sells its product under the name Flax Health. The software is built for skilled nursing facilities. It pulls referral details from portals, summarizes each patient and flags whether the person fits the facility. It also pre-fills intake forms from existing clinical notes and builds claims backed by clinical evidence.
More than 200 care teams use Flax. The company is based in Seattle, and the product is SOC 2 Type II and HIPAA compliant. Trent Hazy is chief executive officer and co-founded the company with David Kartchner. In September 2025 the company announced a $3.5 million pre-seed round co-led by Sorenson Capital and Pear VC.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | Nov 6, 2026 | $7,894,996of $12.5M target | 13 | $607K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by Flax Health
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Sep 2, 2025 | Pre-seed | $3.5 million | Sorenson Capital and Pear VC (co-led) (co-leads), Strategic angel investors and skilled nursing operators | Flax Health blog post ↗ Business Wire release ↗ |
Why Investors Backed Flax Health
Flax Technologies, Inc., which runs its product as Flax Health, sells AI software that handles referral, intake and billing paperwork for skilled nursing facilities. Pear VC and Sorenson Capital co-led a $3.5 million pre-seed round announced in September 2025. More than 200 care teams use the product. The co-founders are a former builder of Microsoft automation products and a Georgia Tech PhD in healthcare AI.
The problem it targets
Flax's founders describe skilled nursing as a sector with heavy reimbursement and compliance demands. In their view, the root problem is clinical data that is fragmented and hard to use. Chief executive officer Trent Hazy argues that the volume of requirements, rising costs and staffing shortages make it harder than ever to focus on patient care.
What the product does
Flax runs on three AI modules. Admissions Intelligence reads referral portals, summarizes the patient's data and flags risks. Intake Automation pre-fills forms and improves MDS accuracy. Claims Support drafts claims and appeals backed by clinical evidence, aiming to raise recovery and cut write-offs. The home page adds a care step for care plans and a goal of fewer rehospitalizations. The admissions tool is built to answer referrals in two minutes.
Progress so far
Across customers, staff save an average of 11 hours a week. Some organizations have cut admissions team headcount, which added more than $70,000 to their bottom line. Customers also improve CMI and see thousands of dollars in added weekly revenue. One director of admissions, Deachie Queza, says referral checks that once drained the team's time now feel effortless.
Who backs it
Sorenson Capital and Pear VC co-led the $3.5 million pre-seed round announced on September 2, 2025. Strategic angel investors and skilled nursing operators also backed it. Trent Hazy previously built AI and automation products at Microsoft. David Kartchner earned a PhD in AI for healthcare at Georgia Tech, where he worked on pulling insights from clinical documentation.
We wrote this summary from public statements by Flax Health and its investors. It is not investment advice.
Flax Health in the News
Leadership Team
Executive officers and directors listed on Flax Health's Form D filed Nov 6, 2026.
